Alnylam Pharmaceuticals
Price & Volume
Stats
See moreOpen | $320.61 |
Previous Close | $322.11 |
Day Range | $320.04-$331.86 |
52W Range | $225.84-$495.55 |
Market Cap | $42.7B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $3.7B |
Revenue Growth (YoY) | 84.9% |
Gross Profit (12 Mos) | $3B |
Diluted EPS | $2.32 |
News
See moreYahoo Finance • 11 hours ago
Oligonucleotides Market Research and Competitive Landscape Report 2026 Featuring Novartis, Astellas, Alnylam Pharmaceuticals, Ionis Pharmaceuticals
Yahoo Finance • yesterday
Is Alnylam Pharmaceuticals (ALNY) The Best Growth Stock?
Yahoo Finance • 4 days ago
Alnylam Pharmaceuticals (ALNY) Achieved Free Cash Flow Breakeven in 2025
Yahoo Finance • 7 days ago
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
About
CEO | Dr. Yvonne L. Greenstreet M.B.A., M.D. |
CFO | Mr. Jeffrey V. Poulton M.B.A. |
Address | 675 West Kendall Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2,500 |
